[Etiopathogenetic differentiation of inflammatory cardiomyopathy. Immunosuppression and immunomodulation].
Kühl
U
U
Med. Klinik II Kardiologie und Pulmonologie, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin.
Pauschinger
M
M
Schultheiss
H P
HP
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D002908:Chronic Disease; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009205:Myocarditis / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D009206:Myocardium / Q000276:immunology / Q000473:pathology
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents